J Thorac Cardiovasc Surg 2008;135:718-719
© 2008 The American Association for Thoracic Surgery
Reply to the Editor
Gail Darling, MD, FRCSC
Toronto General Hospital, Division of the University Health Network, University of Toronto, Toronto, Ontario, Canada
|The first 20% of the full text of this article appears below.|
Dr Van Schil's letter clearly enunciates the concern of many surgeons that the combination of chemotherapy and radiation for induction increases the risk of subsequent surgical intervention, whereas the use of induction chemotherapy alone does not. Although the report from Martin and colleagues,1 as well as the data from the Intergroup 0139 trial,2 support this concern, we believe this not to be the case. In our experience, as outlined in our report, the mortalities all occurred early in our experience with this protocol. There were no mortalities . . . [Full Text of this Article]
Copyright © 2008 by The American Association for Thoracic Surgery.